Internal Medicine, Endocrinology, Diabetes, & Metabolism · Toa Baja, PR
NPI
1629162334
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
Aa3 Ave Don Pelayo, Urb.Covadonga
Toa Baja, PR, 00949
Phone (787) 963-1404
Medicare paid, 2024
$12K
139 services
Medicare patients, 2024
67
Average age 76
Drug cost, 2024
$3.8M
17,751 prescriptions
Company payments, 2025
$186
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Maria D Miranda was code 99214 (office e&m - established), 128 times for 62 patients. In total Maria D Miranda billed 139 services in 4 codes, and Medicare paid $12K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-03-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 128 | 62 | $85.28 | $11K |
By year: 2022 $11K for 135 services; 2023 $11K for 143 services; 2024 $12K for 139 services.
Medicare prescription drug claims, 2024
In 2024, the drug Maria D Miranda prescribed most often to Medicare patients was Synthroid (Levothyroxine Sodium), with 2,695 prescriptions and refills. In total Maria D Miranda wrote 17,751 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Synthroid Levothyroxine Sodium | 2,695 | 5,675 | 650 | $264K |
| Metformin Hcl Generic | 617 | 1,440 | 190 | $4,985 |
| Atorvastatin Calcium Generic | 563 | 1,348 | 191 | $6,472 |
| Trulicity Dulaglutide | 560 | 628 | 75 | $625K |
| Jardiance Empagliflozin | 517 | 789 | 121 | $477K |
| Levothyroxine Sodium Generic | 493 | 1,268 | 154 | $8,092 |
| Simvastatin Generic | 484 | 1,276 | 160 | $4,713 |
| Ozempic Semaglutide | 482 | 523 | 72 | $489K |
| Gabapentin Generic | 480 | 946 | 128 | $7,517 |
| Glimepiride Generic | 457 | 1,013 | 128 | $6,042 |
| Rosuvastatin Calcium Generic | 431 | 1,014 | 149 | $6,160 |
| Farxiga Dapagliflozin Propanediol | 421 | 586 | 97 | $340K |
| Lantus Insulin Glargine,hum.Rec.Anlog | 356 | 498 | 72 | $43K |
| Losartan Potassium Generic | 337 | 831 | 115 | $4,228 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 306 | 524 | 77 | $40K |
Brand drugs: 7,896 claims; generic drugs: 9,089 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Maria D Miranda $186 ($186 in general payments such as food, travel and fees) from 3 companies. The largest payer was Genentech USA, Inc. with $94.25.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.